Monitoring of Patient Physiological Parameters in Real Life Using OXYFLEX® Biosensors Versus Standard Monitoring

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer

About this trial

The purpose of this study is to use the OXYFLEX® device in real care conditions during the hospital management of a population of patients from various hospital services. These services include patients from the severe trauma pathway, intensive care, the polyvalent intensive care unit, and the operating room. The objective is to assess the reliability of the data collected by the OXYFLEX® biosensor compared to those obtained from standard monitoring used in these different services and conditions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patient (≥ 18 years old);

in severe traum pathway in the emergency services department

or in the operating room for a general anesthesia procedur or locoregional anesthesia planned for a surgical duration grater than 2 hours

or admitted to intesive care/ general intensive care units.

Disqualifiers

Opposition from the patient or their family to participate in the research ;

Pregnant, parturient or breastfeeding woman ;

Patient under judical protection (guardianship, curatorship …) or legal safeguarding ;

Inability to wear the headband and the sensor (in particular : intracranial neurosurgery, othorhinolaryngology or maxillofacial surgery, debilitating trauma to the head or face …) ;

Trial design

Design model

Single group

Treatments tested in this trial

  • Continuous monitoring of vital constants with OXYFLEX® biosensor.

    Other intervention

    The comparison of physiological data (heart rate, respiratory rate, temperature, pulse oxygen saturation, hemoglobin levels) collected by the OXYFLEX® biosensor with those obtained through standard monitoring over a maximum duration of 10 hours.

Treatment groups

102 Participants
are divided into 1 treatment group
Group A: Patients managed in anesthesia, rehabilitation/instensive care unit and traumatology services.Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

heart rate measurement

The data collected by the OXYFLEX biosensor will be compared to data from standard monitoring using concordance tests, such as the Bland-Altman test, the Intraclass Correlation Coefficient (ICC), and the mean of absolute errors. These analyses will allow for the evaluation of the accuracy and reproducibility of the measurements taken with the OXYFLEX biosensor.

Time frame
for a maximum of 10 hours
2

respiratory rate measurement

The data collected by the OXYFLEX® biosensor will be compared to data from standard monitoring using concordance tests, such as the Bland-Altman test, the Intraclass Correlation Coefficient (ICC), and the mean of absolute errors. These analyses will allow for the evaluation of the accuracy and reproducibility of the measurements taken with the OXYFLEX® biosensor.

Time frame
for a maximum of 10 hours
3

temperature measurement

The data collected by the OXYFLEX® biosensor will be compared to data from standard monitoring using concordance tests, such as the Bland-Altman test, the Intraclass Correlation Coefficient (ICC), and the mean of absolute errors. These analyses will allow for the evaluation of the accuracy and reproducibility of the measurements taken with the OXYFLEX® biosensor.

Time frame
for a maximum of 10 hours
4

pulse oxygen saturation measurement

The data collected by the OXYFLEX® biosensor will be compared to data from standard monitoring using concordance tests, such as the Bland-Altman test, the Intraclass Correlation Coefficient (ICC), and the mean of absolute errors. These analyses will allow for the evaluation of the accuracy and reproducibility of the measurements taken with the OXYFLEX® biosensor.

Time frame
for a maximum of 10 hours

Secondary outcomes

1

Conduct a clinical relevance analysis of the measurements collected by the OXYFLEX® biosensor

The values of blood pressure will be presented as descriptive statistics (mean ± standard deviation, median, and interquartile range if necessary), but no formal statistical analysis is planned at this stage, as the objective is purely exploratory and descriptive.

Time frame
for a maximum of 10 hours
2

Evaluate the data loss rate measured by the OXYFLEX®biosensor, based on the percentage of missing data for each parameter, in relation to the number of expected observations (per minute and/or per hour) over the total monitoring duration.

The analysis of data loss will be based on the calculation of the percentage of missing data for each parameter, taking into account the number of observations expected to be collected per minute and the total duration of monitoring. The duration of each data loss will also be categorized (\<5min, 5-14min; 15-60, 1-4 hours, \>4 hours). The value of the blood pressure measured during the 10 hours of follow-up of the research will also be collected and made available for the OXYFLEX® algorithm.

Time frame
for a maximum of 10 hours
3

Investigate the factors impacting the accuracy of measurements and the relevance of data collected by the OXYFLEX®biosensor

Subgroup analysis of the validity of the collected data, their clinical relevance, and the technical performance of the sensor based on parameters that may alter or bias the measurements.

Time frame
for a maximum of 10 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: